Skip to main content
$3.85 -0.04 (-1.03%) At close · Jul 28
Market Cap
$162.89M
Shares
41.87M

Apyx Medical Corp Earnings Call Transcripts

Every quarterly earnings call for Apyx Medical Corp (APYX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q1
2026-05-27
Apyx Medical Corp Q1 FY2026 Earnings Call
Confident tone AYON body contouring system launch GLP-1 demand tailwind Surgical Aesthetics revenue growth
Revenue
$12.49M
▲ 32.4% YoY
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-10
Apyx Medical Corp Q4 FY2025 Earnings Call
Confident tone AYON body contouring system launch and demand Revenue growth and quarterly results Financial health, cash runway and profitability path
Revenue
$19.16M*
▲ 34.7% YoY
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Apyx Medical Corp Q3 FY2025 Earnings Call
Confident tone AYON Body Contouring System Launch Revenue Growth and Financial Performance GLP-1 Market Opportunity
Revenue
$12.88M
▲ 12.1% YoY
Gross margin
64.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Apyx Medical Corp Q2 FY2025 Earnings Call
Confident tone AYON System Launch China Expansion Renuvion / Advanced Energy
Revenue
$11.37M
▼ 6.4% YoY
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Apyx Medical Corp Q1 FY2025 Earnings Call
Positive tone AYON platform launch Renuvion product performance Cost restructuring and cash management
Revenue
$9.43M
▼ 7.9% YoY
Gross margin
60.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Apyx Medical Corp Q4 FY2024 Earnings Call
Positive tone GLP-1 Tailwind & Surgical Aesthetics Opportunity Advanced Energy Segment Performance Renuvion System Positioning
Revenue
$14.22M*
▼ 3% YoY
Gross margin
63.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Apyx Medical Corp Q3 FY2024 Earnings Call
Positive tone Ayon next-generation platform Operating expense reduction plan Restructuring and workforce reduction
Revenue
$11.49M
▼ 4.1% YoY
Gross margin
60.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Apyx Medical Corp Q2 FY2024 Earnings Call
Balanced tone Guidance and H2 outlook Clinical evidence and Renuvion technology Handpiece growth
Revenue
$12.15M
▼ 10.5% YoY
Diluted EPS
$-0.19
Gross margin
61.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Apyx Medical Corp Q1 FY2024 Earnings Call
Cautious tone Advanced Energy Revenue Decline Renuvion Clinical Evidence and Clearances OEM Segment Growth
Revenue
$10.24M
▼ 15.6% YoY
Diluted EPS
$-0.22
Gross margin
58.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
Apyx Medical Corp Q4 FY2023 Earnings Call
Positive tone Advanced Energy Revenue Growth Capital Equipment Headwinds Renuvion Micro Handpiece Launch
Revenue
$14.66M*
▲ 16.3% YoY
Gross margin
60.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Apyx Medical Corp Q3 FY2023 Earnings Call
Revenue
$11.98M
▲ 31.4% YoY
Diluted EPS
$-0.13
Gross margin
66.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Apyx Medical Corp Q2 FY2023 Earnings Call
Revenue
$13.57M
▲ 31.8% YoY
Diluted EPS
$-0.03
Gross margin
68.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Apyx Medical Corp Q1 FY2023 Earnings Call
Revenue
$12.14M
▼ 2.8% YoY
Diluted EPS
$-0.10
Gross margin
62.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Apyx Medical Corp Q4 FY2022 Earnings Call
Revenue
$12.61M*
▼ 25% YoY
Gross margin
65.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Apyx Medical Corp Q3 FY2022 Earnings Call
Revenue
$9.11M
▼ 23% YoY
Diluted EPS
$-0.17
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Apyx Medical Corp Q2 FY2022 Earnings Call
Revenue
$10.29M
▼ 8.3% YoY
Diluted EPS
$-0.16
Gross margin
67.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Apyx Medical Corp Q1 FY2022 Earnings Call
Revenue
$12.49M
▲ 44.6% YoY
Diluted EPS
$-0.17
Gross margin
65.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
Apyx Medical Corp Q4 FY2021 Earnings Call
Revenue
$16.82M*
▲ 46.8% YoY
Gross margin
72.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Apyx Medical Corp Q3 FY2021 Earnings Call
Revenue
$11.83M
▲ 70.1% YoY
Diluted EPS
$-0.12
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Apyx Medical Corp Q2 FY2021 Earnings Call
Revenue
$11.22M
▲ 161.3% YoY
Diluted EPS
$-0.12
Gross margin
67.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
Apyx Medical Corp Q1 FY2021 Earnings Call
Revenue
$8.64M
▲ 72.9% YoY
Diluted EPS
$-0.14
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-13
Apyx Medical Corp Q4 FY2020 Earnings Call
Revenue
$11.46M*
▲ 36.8% YoY
Gross margin
67.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Apyx Medical Corp Q3 FY2020 Earnings Call
Revenue
$6.95M
▼ 8.2% YoY
Diluted EPS
$-0.11
Gross margin
67.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Apyx Medical Corp Q2 FY2020 Earnings Call
Revenue
$4.30M
▼ 35.4% YoY
Diluted EPS
$-0.14
Gross margin
48.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Apyx Medical Corp Q1 FY2020 Earnings Call
Revenue
$5.00M
▼ 11.2% YoY
Gross margin
59.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Apyx Medical Corp Q4 FY2019 Earnings Call
Revenue
$8.38M
▲ 43.4% YoY
Gross margin
66.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–26 of 26 earnings calls
Key facts CIK 719135 CUSIP 03837C106 13F (30d) 8 filings 8 filers Visit website